In 2000, Arturo Licenziati established the R&D laboratories in Manno. Six years later, one of the IBSA group’s most advanced facilities was born: a plant entirely dedicated to the production of softgel capsules. This versatile and ever-expanding pharmaceutical form lends itself to multiple therapeutic applications.
The Manno site quickly established itself as a centre of excellence, even earning approval from the US Food and Drug Administration (FDA). By combining scientific research and industrial production, IBSA creates cutting-edge products in a highly regulated and competitive environment.